Stay updated on Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.
Latest updates to the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer now shows Revision: v3.3.3, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check46 days agoChange DetectedThe government funding operating status notice was removed, a non-critical banner that does not change the trial data or its history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check60 days agoChange DetectedNo significant changes detected between the old and new screenshots; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check89 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference11%
- Check96 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.3%
Stay in the know with updates to Cobimetinib in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib in Relapsed Multiple Myeloma Clinical Trial page.